648 related articles for article (PubMed ID: 9442783)
21. Dorzolamide. A review of its pharmacology and therapeutic potential in the management of glaucoma and ocular hypertension.
Balfour JA; Wilde MI
Drugs Aging; 1997 May; 10(5):384-403. PubMed ID: 9143858
[TBL] [Abstract][Full Text] [Related]
22. Studies on the mechanism of action of timolol and on the effects of suppression and redirection of aqueous flow on outflow facility.
Kiland JA; Gabelt BT; Kaufman PL
Exp Eye Res; 2004 Mar; 78(3):639-51. PubMed ID: 15106944
[TBL] [Abstract][Full Text] [Related]
23. Additive effect of dorzolamide or carteolol to latanoprost in primary open-angle glaucoma: a prospective randomized crossover trial.
Maruyama K; Shirato S
J Glaucoma; 2006 Aug; 15(4):341-5. PubMed ID: 16865013
[TBL] [Abstract][Full Text] [Related]
24. Additive ocular hypotensive effect of latanoprost and acetazolamide. A short-term study in patients with elevated intraocular pressure.
Rulo AH; Greve EL; Hoyng PF
Ophthalmology; 1997 Sep; 104(9):1503-7. PubMed ID: 9307648
[TBL] [Abstract][Full Text] [Related]
25. Effects of ocular administration of ophthalmic 2% dorzolamide hydrochloride solution on aqueous humor flow rate and intraocular pressure in clinically normal cats.
Rankin AJ; Crumley WR; Allbaugh RA
Am J Vet Res; 2012 Jul; 73(7):1074-8. PubMed ID: 22738060
[TBL] [Abstract][Full Text] [Related]
26. Topical dorzolamide 2%/timolol 0.5%: a review of its use in the treatment of open-angle glaucoma.
Ormrod D; McClellan K
Drugs Aging; 2000 Dec; 17(6):477-96. PubMed ID: 11200308
[TBL] [Abstract][Full Text] [Related]
27. Comparison of topical brinzolamide 1% and dorzolamide 2% eye drops given twice daily in addition to timolol 0.5% in patients with primary open-angle glaucoma or ocular hypertension.
Michaud JE; Friren B;
Am J Ophthalmol; 2001 Aug; 132(2):235-43. PubMed ID: 11476685
[TBL] [Abstract][Full Text] [Related]
28. Diurnal and nocturnal variations in aqueous humor dynamics of patients with ocular hypertension undergoing medical therapy.
Gulati V; Fan S; Zhao M; Maslonka MA; Gangahar C; Toris CB
Arch Ophthalmol; 2012 Jun; 130(6):677-84. PubMed ID: 22332206
[TBL] [Abstract][Full Text] [Related]
29. The use of dorzolamide and pilocarpine as adjunctive therapy to timolol in patients with elevated intraocular pressure. The Dorzolamide Additivity Study Group.
Strahlman ER; Vogel R; Tipping R; Clineschmidt CM
Ophthalmology; 1996 Aug; 103(8):1283-93. PubMed ID: 8764800
[TBL] [Abstract][Full Text] [Related]
30. Comparative acute effects of brimonidine 0.2% versus dorzolamide 2% combined with beta-blockers in glaucoma.
Centofanti M; Manni G; Gregori D; Cocco F; Lorenzano D; Bucci MG
Graefes Arch Clin Exp Ophthalmol; 2000 Apr; 238(4):302-5. PubMed ID: 10853928
[TBL] [Abstract][Full Text] [Related]
31. The effect of dorzolamide on aqueous humor dynamics in normal human subjects during sleep.
Vanlandingham BD; Maus TL; Brubaker RF
Ophthalmology; 1998 Aug; 105(8):1537-40. PubMed ID: 9709770
[TBL] [Abstract][Full Text] [Related]
32. A controlled clinical trial of dorzolamide: a single-centre subset of a multicentre study.
Simpson AJ; Gray TB; Ballantyne C
Aust N Z J Ophthalmol; 1996 Feb; 24(1):39-42. PubMed ID: 8743003
[TBL] [Abstract][Full Text] [Related]
33. Additive intraocular pressure reduction effect of fixed combination of maleate timolol 0.5%/dorzolamide 2% (Cosopt) on monotherapy with latanoprost (Xalatan) in patients with elevated intraocular pressure: a prospective, 4-week, open-label, randomized, controlled clinical trial.
Hatanaka M; Reis A; Sano ME; Susanna R
J Glaucoma; 2010; 19(5):331-5. PubMed ID: 19730119
[TBL] [Abstract][Full Text] [Related]
34. Aqueous humor flow in normal human eyes treated with brimonidine and dorzolamide, alone and in combination.
Tsukamoto H; Larsson LI
Arch Ophthalmol; 2004 Feb; 122(2):190-3. PubMed ID: 14769595
[TBL] [Abstract][Full Text] [Related]
35. Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.
Lupinacci AP; Netland PA; Fung KH; Evans D; Zhao Y
Adv Ther; 2008 Mar; 25(3):231-9. PubMed ID: 18369537
[TBL] [Abstract][Full Text] [Related]
36. Efficacy and side effects of latanoprost monotherapy compared to adding dorzolamide to timolol in patients with glaucoma and ocular hypertension--a three-month randomised study. Spanish Latanoprost Study Group.
García Sanchez J
Eur J Ophthalmol; 2000; 10(3):198-204. PubMed ID: 11071026
[TBL] [Abstract][Full Text] [Related]
37. Results of the European Glaucoma Prevention Study.
Miglior S; Zeyen T; Pfeiffer N; Cunha-Vaz J; Torri V; Adamsons I;
Ophthalmology; 2005 Mar; 112(3):366-75. PubMed ID: 15745761
[TBL] [Abstract][Full Text] [Related]
38. A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Dorzolamide Dose-Response Study Group.
Strahlman E; Tipping R; Vogel R
Am J Ophthalmol; 1996 Aug; 122(2):183-94. PubMed ID: 8694086
[TBL] [Abstract][Full Text] [Related]
39. Brinzolamide : a review of its use in the management of primary open-angle glaucoma and ocular hypertension.
Cvetkovic RS; Perry CM
Drugs Aging; 2003; 20(12):919-47. PubMed ID: 14565787
[TBL] [Abstract][Full Text] [Related]
40. A comparison of the effectiveness of dorzolamide and acetazolamide in preventing post-operative intraocular pressure rise following phacoemulsification surgery.
Zohdy GA; Rogers ZA; Lukaris A; Sells M; Roberts-Harry TJ
J R Coll Surg Edinb; 1998 Oct; 43(5):344-6. PubMed ID: 9803110
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
